Diabetic ketoacidosis
It refers to the syndrome of pathological changes such as hyperglycemia, hyperketosis, ketonuria, dehydration, electrolyte imbalance, metabolic acidosis, etc. caused by the obvious insulin deficiency and inappropriate increase of glucose hormones in diabetic patients under the influence of various inducements. It is one of the common emergencies in internal medicine.
Related Drugs
Insulin injection
Indication: 1. Type Ⅰ diabetes; 2. Type Ⅱ diabetes with severe infection, trauma, major surgery and other severe stress situations, as well as cardiovascular and cerebrovascular complications, kidney or retinal diseases; 3. Diabetic ketoacidosis, hyperglycemia non-ketotic hyperosmolar coma; 4. Long-term type Ⅱ diabetes with indeed low plasma insulin levels, which are not satisfactorily controlled by reasonable diet, physical activity and oral hypoglycemic drugs, and type Ⅱ diabetes with contraindications to oral hypoglycemic drugs, such as pregnancy and breastfeeding; 5. Adult or elderly diabetic patients with acute onset, significant weight loss and obvious emaciation; 6. Gestational diabetes; 7. Diabetes secondary to severe pancreatic disease; 8. For severe malnutrition, emaciation, intractable vomiting during pregnancy, and early stage of cirrhosis, glucose and small doses of insulin can be given intravenously at the same time to promote tissue utilization of glucose.
Manufacturer:
SPH NO.1 Biochemical & Pharmaceutical Co., Ltd.
Insulin injection
Indication: 1. Type Ⅰ diabetes; 2. Type Ⅱ diabetes with severe infection, trauma, major surgery and other severe stress situations, as well as cardiovascular and cerebrovascular complications, kidney or retinal diseases; 3. Diabetic ketoacidosis, hyperglycemia non-ketotic hyperosmolar coma; 4. Long-term type Ⅱ diabetes with indeed low plasma insulin levels, which are not satisfactorily controlled by reasonable diet, physical activity and oral hypoglycemic drugs, and type Ⅱ diabetes with contraindications to oral hypoglycemic drugs, such as pregnancy and breastfeeding; 5. Adult or elderly diabetic patients with acute onset, significant weight loss and obvious emaciation; 6. Gestational diabetes; 7. Diabetes secondary to severe pancreatic disease; 8. For severe malnutrition, emaciation, intractable vomiting during pregnancy, and early stage of cirrhosis, glucose and small doses of insulin can be given intravenously at the same time to promote tissue utilization of glucose.
Manufacturer:
Hangzhou Guoguang Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Nanjing CHANG AO Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Hainan Zhonghe Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Qingdao Guoda Biopharmaceutical Co., Ltd.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Jiangsu Haian Pharmaceutical Co., Ltd.